ARSUF Stock - Fagron N.V.
Unlock GoAI Insights for ARSUF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $871.96M | $762.99M | $683.88M | $573.81M | $555.97M |
| Gross Profit | $395.68M | $332.61M | $286.17M | $247.50M | $246.73M |
| Gross Margin | 45.4% | 43.6% | 41.8% | 43.1% | 44.4% |
| Operating Income | $130.70M | $108.63M | $97.91M | $87.44M | $88.74M |
| Net Income | $80.55M | $70.55M | $69.61M | $61.00M | $59.60M |
| Net Margin | 9.2% | 9.2% | 10.2% | 10.6% | 10.7% |
| EPS | $1.10 | $0.97 | $0.96 | $0.84 | $0.83 |
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Visit WebsiteEarnings History & Surprises
ARSUFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Jul 31, 2025 | — | — | — | — |
Q1 2025 | Feb 20, 2025 | — | $0.57 | — | — |
Q4 2024 | Oct 10, 2024 | — | $0.60 | — | — |
Q2 2024 | May 21, 2024 | — | $0.56 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.49 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.51 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.51 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.53 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.44 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.48 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.49 | — | — |
Q4 2019 | Dec 31, 2019 | $0.52 | $0.44 | -15.1% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $0.20 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.40 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.30 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.42 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.33 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.51 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.49 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-1.64 | — | — |
Latest News
Frequently Asked Questions about ARSUF
What is ARSUF's current stock price?
What is the analyst price target for ARSUF?
What sector is Fagron N.V. in?
What is ARSUF's market cap?
Does ARSUF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ARSUF for comparison